Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-06-08
2000-08-29
Allen, Marianne P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 530350, 530399, C07K 14475, C07K 1450, A61K 3818
Patent
active
061108936
ABSTRACT:
Disclosed is a human Fibroblast growth factor-11 polypeptide and DNA(RNA) encoding such polypeptide. Also provided is a procedure for producing such polypeptide by recombinant techniques. Also disclosed are methods for utilizing such polypeptide for promoting wound healing for example as a result of burns and ulcers, to prevent neuronal damage associated with stroke and due to neuronal disorders and promote neuronal growth, and to prevent skin aging and hair loss, to stimulate angiogenesis, mesodermal induction in early embryos and limb regeneration. Antagonists against such polypeptides and their use as a therapeutic to prevent abnormal cellular proliferation, hyper-vascular diseases and epithelial lens cell proliferation are also disclosed. Diagnostic methods for detecting mutations in the coding sequence and alterations in the concentration of the polypeptides in a sample derived from a host are also disclosed.
REFERENCES:
patent: 4868113 (1989-09-01), Jaye et al.
patent: 5155214 (1992-10-01), Baird et al.
patent: 5763214 (1998-06-01), Hu et al.
patent: 5876967 (1999-03-01), Nathans et al.
Burgess et al., Annu. Rev. Biochem. 58: 575-606 (1989).
Aaronson, S.A. et al., Keratinocyte Growth Factor :62-77(1992).
Jaye, M., et al., Science, 233:541-545 (1986).
Klagsbrun, M., et al., Progress in Growth Factor. 1:207-235 (1989).
GeneSeq Accession No. T58316 (Apr. 21, 1997).
GeneSeq Accession No. T86315 (Mar. 21, 1998).
GeneSeq Accession No. V21386 (Aug. 14, 1998).
GenBank Accession No. T09003 (Aug. 3, 1993).
GenBank Accession No. T08948 (Aug. 3, 1993).
GenBank Accession No. R59031 (May 23, 1995).
Terada et al., Origins of Human Cancer: A Comprehensive Review (Brugge et al., eds.); Cold Spring Harbor, New York, 1990, pp. 675-683.
Basilico et al. (1992) Advances in Cancer Research 59:115-165.
Barinaga (1994) Science 264:772-774.
Geneseq Acc, No. Q61387 (Mar. 16, 1994).
Genbank Acc. No. Z45127 (Nov. 14, 1994).
Genbank Acc. No. M79229 (May 26, 1992).
Gospodarowicz, D., Cell Biology Reviews 25(4):307-314 (1991).
Hu Jing-Shan
Rosen Craig A.
Allen Marianne P.
Human Genome Sciences Inc.
LandOfFree
Fibroblast growth factor 11 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibroblast growth factor 11, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibroblast growth factor 11 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1249940